Hypertension is a leading cause of morbidity and mortality worldwide. In Japan, 60% of men and 45% of women over 30 years old have prevalent hypertension, and approximately 100,000 deaths are attributed to hypertension every year. 1 Growing body of evidences have indicated that even slight elevation in blood pressure (BP) is associated with increased cardiovascular incidence and mortality. It was suggested that preclinical hypertension may result in target organ damages. 2-4 Furthermore, it has been shown that prognostic attribution of hypertension to cardiovascular mortality is important, especially in younger population. 2 Therefore, it is necessary to identify and treat subjects at high risk for clinical hypertension, especially in younger subjects. However, screening of those high-risk subjects before incident hypertension has not been established because of scarce of evidences for identifying subjects at high risk for hypertension.
METHODS

Study population
The Yamagata (Takahata) study is an observational prospective cohort study formed part of the Molecular Epidemiological Study utilizing the resources of Regional Characteristics of 21 st Century Centers of Excellence (COE) Program and the Global COE Program in Japan. Details of the study methodology have been described previously. 10, 11 Briefly, all residents aged 40 years or older were invited to participate in a community-based annual health check in Takahata town, Japan. From 2004 through to 2006, a total of 3,520 subjects (1,579 males and 1,941 females) were enrolled in the cohort. 12 Of those, subjects with prevalent hypertension and/or cardiovascular disease (n = 2,090, 59%) and lack of H-FABP measurement at baseline examination (n = 6), those with renal insufficiency defined as estimated glomerular filtration rate (eGFR) 60 ml/min/1.73 m 2 or below (n = 245) were excluded. Of the remaining 1,179 subjects, 655 subjects were excluded from final statistical analyses (9 subjects died, 5 subjects migrated out of study area, 15 subjects withdraw of agreement, and 626 subjects did not attend follow-up survey), and 524 subjects who attended at least 1 of 2 follow-up examinations (2009 and 2011) were eligible for the final statistical analyses. Baseline characteristics were similar between 524 subjects included and 655 subjects excluded from the final analyses. All procedures were performed in accordance with the Helsinki Declaration. The study was approved by the ethics committee of Yamagata University School of Medicine and all participants gave written informed consent.
Measurements of H-FABP
Blood samples were collected from subjects who had been fasting overnight, and the samples were immediately transferred to chilled tubes. Serum concentrations of H-FABP were measured using a 2-step sandwich enzyme-linked immunosorbent assay kit (MARKIT-M H-FABP, Dainippon Pharmaceutical, Tokyo, Japan) as reported previously. 13 Follow-up measurements of H-FABP were performed for subjects attended follow-up examination in 2011 (n = 337), as same methods mentioned above.
Measurements of BP and definition of incident hypertension
BP was measured by sufficiently experienced technicians using a mercury sphygmomanometer after resting in a seated position at least 5 minutes. The mean of at least 2 measurements was adopted for BP. Hypertension was defined as mean SBP ≥140 mm Hg, and/or mean DBP ≥90 mm Hg, and/or the use of antihypertensive medication. Incident hypertension was defined as newly developed hypertension based on the BP values of follow-up examination and/or self-reported onset of hypertension during follow-up, and/or the use of antihypertensive medication.
Other measurements and definitions
Subjects used a self-report questionnaire to document their medical histories, smoking habits, current use of medications, and clinical symptoms. Amount of ethanol consumption was self-reported. The lifetime consumption of cigarette smoking was assessed using smoking index (number of cigarette per day multiplied by number of years of smoking). Body mass index (BMI) was calculated by the following equation (body weight in kilogram divided by square of body height in meter). Dyslipidemia was defined as lowdensity lipoprotein cholesterol ≥140 mg/dl, high-density lipoprotein cholesterol <40 mg/dl, triglyceride ≥150 mg/ dl, or on lipid-lowering medication. Diabetes mellitus was defined as fasting blood glucose ≥126 mg/dl, HbA1c ≥6.5%, or the use of antidiabetic medication. eGFR was calculated by the modification of diet in renal disease equation with the Japanese coefficient. 14 Estimated daily salt intake was calculated using a morning spot urine specimen with the Tanaka's equation. 15 Physical activity level was estimated by self-reported physical activity on a representative day, and expressed as a sum of metabolic equivalents of all activity.
Statistical analysis
All results are presented as mean ± SD for continuous values and as percentages of the total number of patients for categorical variables. Skewed variables are presented as medians and interquartile ranges. Student's unpaired t test and the chi-square test were used for comparisons of continuous and categorical variables between 2 groups, respectively. If data were not distributed normally, Mann-Whitney U test was used. Since H-FABP showed skewed distribution, we utilized logarithmically transformed values for statistical analysis. Subjects were categorized into 2 groups based on H-FABP levels at baseline. H-FABP ≥4.3 ng/ml was defined as myocardial damage as specified previously. 16 Cox proportional hazard regression analyses were performed to investigate whether H-FABP was associated with incident hypertension. Significant variables in univariate analyses along with possible confounders which affects H-FABP levels and hypertension were utilized for multivariate adjustment. Goodness-of-fit for each parameter in regression model was analyzed using the Wald test. The proportional hazards assumption was examined with log-minus-log plots. We calculated the net reclassification index and the integrated discrimination index to examine the validity of the model according to the addition of H-FABP to the prediction model. 17 P values of <0.05 were considered significant. All analyses were performed with a standard statistical program packages (JMP version 10; SAS Institute, Cary, NC; R 3.3.2 with additional packages including Rcmdr, Epi, pROC, and PredictABLE).
RESULTS
Baseline characteristics of the study subjects
Overall, enrolled subjects were 58 ± 9 years at baseline, and women comprised 53% of them. The mean BP was 123 ± 11/74 ± 8 mm Hg, and median H-FABP was 3.0 ng/ ml (interquartile range, 2.3-4.0 ng/ml), and mean log 10 H-FABP was 0.48 ± 0.18 at baseline. Table 1 shows the baseline characteristics of the subjects stratified by the presence of myocardial damage. Subjects with myocardial damage at baseline were more likely to be male and older, more likely to have higher SBP, Framingham risk score, and uric acid and lower eGFR than those without.
H-FABP and incident hypertension
During a median follow-up period of 6.2 years, 177 subjects developed hypertension (crude cumulative incidence 34%; 54.1 per 1,000 person-years). Baseline log 10 H-FABP levels in subjects with incident hypertension were significantly higher than in those without (0.53 ± 0.18 vs. 0.46 ± 0.18, P < 0.0001), and the incidence of hypertension was significantly higher in subjects with myocardial damage than in those without (54% [89.7 per 1,000 person-years], and 29% [45.7 per 1,000 person-years]; P < 0.0001). Relative risk (RR) of myocardial damage for incident hypertension was 1.87 (95% confidence interval, 1.48-2.36) (Table 2A) .
Association between myocardial damage and incident hypertension in each BP category
To examine whether the impact of myocardial damage was influenced by BP category, we performed subgroup analysis. Subjects were divided into 3 groups based on baseline BP (optimal BP category: SBP <120 and DBP <80 mm Hg; normal BP category: 120 ≤SBP <130 mm Hg or 80 ≤DBP <85 mm Hg; high-normal BP category: 130 ≤SBP <139 mm Hg or 85 ≤DBP <90 mm Hg). Subjects with myocardial damage had significantly higher incidence of hypertension irrespective of BP subgroups (optimal BP category: 31% vs. 9%, P = 0.0017; normal BP category: 44% vs. 24%, P = 0.0356; high-normal BP category: 71% vs. 47%, P = 0.0036). RR (95% confidence interval) of myocardial damage for incident hypertension was higher in subjects with lower BP category than in those with higher BP category (optimal BP category: (Table 2A) .
Association between myocardial damage and incident hypertension in each age category
Further subgroup analysis was performed to examine whether the impact of myocardial damage was influenced by age category. Subjects were divided into 3 groups based on age at baseline examination (age <60 years; 60 ≤age <70 years; age ≥70 years). Subjects with myocardial damage had significantly higher incidence of hypertension in younger 2 age category (age <60: 44% vs. 22%, P = 0.0061; 60 ≤age <70: 60% vs. 38%, P = 0.0088), but not in the highest age category (age ≥70: 55% vs. 49%, P = 0.6471). RR (95% confidence interval) of myocardial damage for incident (Table 2B) .
Cox proportional hazard regression analyses
In univariate Cox proportional hazard regression analysis, H-FABP was significantly associated with incident hypertension (Table 3 ). In multivariate analysis adjusted for potential confounders including age, sex, BMI, hemoglobin, uric acid, eGFR, and baseline SBP and DBP, myocardial damage was significantly associated with incident hypertension (adjusted hazard ratio, 1.80; 95% confidence interval, 1.26-2.54; P = 0.0014).
Sensitivity analyses
As sensitivity analyses, we performed multivariate analysis using other models (model 2: adjusted for only significant variables in univariate analyses including age, sex, BMI, SBP, DBP, hemoglobin, and uric acid; model 3: adjusted for variables which affects BP levels including age, sex, BMI, ethanol consumption, smoking index, SBP, DBP, estimated salt intake, metabolic equivalents, and eGFR). Irrespective of model conformation, presence of myocardial damage was significantly associated with incident hypertension (Supplementary Table 1) .
Risk reclassification by H-FABP
To determine whether the addition of myocardial damage to the prediction model improves risk reclassification, net reclassification index and integrated discrimination index were calculated ( Table 4 ). The prediction model including age, sex, BMI, SBP, DBP, hemoglobin, uric acid, and eGFR. The addition of myocardial damage significantly increased the net reclassification index (0.3093, 95% confidence interval, 0.1487-0.4699; P = 0.0002) and the integrated discrimination index (0.0233, 95% confidence interval, 0.0084-0.0383; P = 0.0023). With the addition of myocardial damage, 25 subjects (14.1%) and 23 subjects (13.0%) were reclassified upward and downward risk category respectively, compared with the prediction model alone in subjects with incident hypertension. Similarly, 31 subjects (8.9%) and 45 subjects (13.0%) were reclassified upward and downward, respectively, in subjects without incident hypertension (Supplementary Table 2 ).
Association between trajectory of myocardial damage and incident hypertension
Next, we investigated the association between changes in H-FABP and incident hypertension. Follow-up H-FABP levels were available for subjects who attended follow-up examination in 2011 (n = 337). Trajectory of myocardial damage was categorized as follows: no myocardial damage (H-FABP <4.3 ng/ml at both baseline and follow-up); transient myocardial damage (H-FABP ≥4.3 ng/ml at baseline and H-FABP <4.3 ng/ml at follow-up or H-FABP <4.3 ng/ml at baseline and H-FABP ≥4.3 ng/ml at follow-up); persistent myocardial damage (H-FABP ≥4.3 ng/ml at both baseline and followup). Subjects with persistent myocardial damage had significantly higher incidence of hypertension compared with those with no myocardial damage (RR 2.25). Interestingly, subjects with transient myocardial damage also showed higher incidence of hypertension (RR 1.61) (Figure 1) .
DISCUSSION
In the present study, we found that baseline H-FABP level independently predicts incident hypertension in normotensive Japanese general population without history of cardiovascular disease. Furthermore, even transiently detected high H-FABP levels were associated with future hypertension development.
Myocardial damage and incident hypertension
Atherosclerosis Risk in Communities (ARIC) study showed that myocardial damage as assessed by high-sensitivity cardiac troponin T was independent predictor of incident hypertension. 5 The present study showed that myocardial damage was independently associated with incident hypertension in Japanese general population using H-FABP, another sensitive marker for myocardial damage. RR of myocardial damage for incident hypertension was greater in lower BP category than in higher BP category, which was consistent with ARIC study. Furthermore, our study revealed that the impact of myocardial damage on incident hypertension was greater in younger subjects compared with older subjects. Young subjects belong to optimal or normal BP category seem to less likely to develop hypertension compared with old subjects with high-normal BP category. However, previous epidemiological studies have shown that preclinical hypertension is already associated with higher cardiovascular incidence and mortality, suggesting that target organ damages progress before incident hypertension. [2] [3] [4] 7 Furthermore, the attributable impact of BP on cardiovascular mortality is much stronger in younger subjects than in older subjects. 2 Considering difficulty of screening for hypertension in apparently healthy normotensive younger subjects, combined assessment of BP and H-FABP may serve as an effective screening strategy to identify subjects at high risk for incident hypertension.
Possible mechanism of the association between myocardial damage and incident hypertension
There are several possible reasons why preceding myocardial damage predicts future development of hypertension. Considering the relationship between BP and myocardial damage, central BP is thought to be more important rather than peripheral BP, because of its closer anatomical proximity to the heart. Although diagnosis of hypertension is practically made with brachial cuff sphygmomanometer, there has shown to be differences between brachial BP and aortic BP. 18 An observational study demonstrated that over 70% of subjects with high-normal brachial BP had similar aortic BP levels to that of subjects with stage 1 hypertension, 19 which explains why central BP is more strongly related to future cardiovascular events than brachial BP. 20 Presence of myocardial damage in normotensive subjects might result from the underlying central hemodynamic stress which was undetectable by brachial BP in the present study. However, central BP is not as popular as brachial BP because of need of specific equipment. Measurement of H-FABP might be clinically relevant since it provides meaningful information beyond brachial BP values.
Another possible explanation is that myocardial damage reflect presence of masked hypertension at baseline in apparently normotensive subjects, which might become sustained hypertension during follow-up. Masked hypertension is associated with poor cardiovascular outcomes comparable to sustained hypertension. 20 It has been reported that subjects with conventional cardiovascular risk factors are more likely to have masked hypertension. 21, 22 Since accumulating cardiovascular risk factors are associated with myocardial damage, 6 myocardial damage at baseline might be associated with comorbid masked hypertension.
The present study showed results consistent with the ARIC study. However, main difference between the ARIC study and the present study is how to assess myocardial damage, that is, H-FABP or high-sensitivity cardiac troponin T. The location of H-FABP gene is reported to be on chromosome 1, which is a quantitative trait locus linked to hypertension. Previous study has demonstrated that the activation of H-FABP gene is regulated by the activation of sympathetic nervous systems, and the H-FABP gene polymorphism is associated with essential hypertension. 23 Although the present study was observational-fashion and was not designed to determine causal relationship, these facts imply the pathophysiological linkage between H-FABP and hypertension rather than merely as a result of reverse causality.
To our knowledge, the present study was first to show the association between trajectory of myocardial damage and incident hypertension. Interestingly, not only persistent myocardial damage but also transient myocardial damage was associated with future incident hypertension. Although H-FABP levels vary according to the severity of myocardial damage, 24 our results suggested that single-point measurement might be sufficient for risk prediction of incident hypertension. Future study is required to elucidate whether early intervention improves clinical outcome in normotensive subjects with myocardial damage.
Strengths and limitations
The strengths of our study include a well-characterized study design with rigorous history taking, laboratory and demographic data collected by experienced staffs. This study contains several limitations as well. Since the diagnosis of incident hypertension was predominantly based on 2-point measurements of brachial BP at health check-up, white coat hypertension and masked hypertension might influence the results. In addition, since participation for the current cohort was entrusted to personal intention, highly health-conscious subjects might be selected at baseline. Moreover, assessment of myocardial damage was totally based on the H-FABP levels because of lack of echocardiographic assessment. Therefore, subjects with elevated H-FABP levels might include those with subclinical heart diseases which could affect incident hypertension. Furthermore, measuring myocardial damage is more expensive than measuring BP. However, our findings suggest that subjects with normal BP but with myocardial damage might be required further screening to detect hypertension, which may reduce future health care costs by preventing cardiovascular diseases. Therefore, further studies are required to determine in whom myocardial damage should be assessed to maximize the cost-effectiveness. Finally, the association between central BP and myocardial damage could not be investigated in the present study.
In conclusion, preceding subclinical myocardial damage was independently associated with incident hypertension in a normotensive Japanese general population.
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